Dear Colleague,


It is our great pleasure to welcome you to The Miami Debates in Hematologic Malignancies Virtual Conference which will take place on January 27, 2022.


The aims of the conference are to provide an up-to-date review of the latest news in the field of hematologic malignancies. The content of the meeting will focus on clinical management. Also, novel scientific data will be reviewed and discussed from a clinical perspective. The format of the meeting will be a combination of focused lectures and debates centered around controversial topics.


We will bring together international leaders in the field of clinical hematology and oncology to debate and deliver talks that are idea-focused, from the basic mechanisms to the present and future therapies.


The Conference will focus on the following key areas:


  • Optimal treatments for newly diagnosed and relapsed patients
  • Bispecific and conjugated monoclonal antibodies
  • Chemotherapy-free treatments
  • Minimal residual disease (MRD) testing in the clinic
  • CAR T cell and CAR NK cell therapies
  • Future role of bone marrow transplant
  • New drugs in development

We look forward to seeing you at The Miami Debates in Hematologic Malignancies.



C. Ola Landgren M.D., Ph.D.
Conference Chair


Meet our Expert Speakers

Rafael Fonseca

Mayo Clinic, Scottsdale, AZ

Rafael Fonseca, MD, is the Getz Family Professor of Cancer, Professor of Medicine, Chief Innovation Officer, a consultant in the… READ MORE
Ann LaCasce

Dana-Farber Cancer Institute, Boston, MA

Dr. Ann LaCasce completed training in internal medicine at Brigham and Women’s Hospital in Boston, where she later served as… READ MORE
Suzanne Lentzsch

Columbia University, NY

As the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University, I have focused on establishing a highly… READ MORE
John Leonard

Weill Cornell Medicine, NY

John P. Leonard, M.D., is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Senior Associate Dean… READ MORE
Tom Martin

University of California San Francisco, CA

Thomas G. Martin III, MD, is Director of the Hematology Malignancies Research Committee and Co-Director of the Myeloma Program at… READ MORE
Craig Moskowitz

Sylvester Comprehensive Cancer Center, University of Miami, FL

I am the Physician-in-Chief, Oncology Service Line at the Sylvester Cancer Center and Professor of Medicine at the Miller School… READ MORE
Wendy Stock

University of Chicago, IL

Dr. Stock obtained her BS in biology from the University of Illinois, a MA in zoology from the University of… READ MORE
All Speakers


2 Months On-Demand Access


Complimentary Registration for HCPs (except Industry)


Participate in lively debates

Conference Sponsors

All Sponsors

Contact Us

Please drop us a line with any questions or comments you may have.

We look forward to hearing from you.